The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Charles River Labs Intl

  • CRL
  • NYSE
  • Other Services
  • Latest 57.62
  • Currency US$
  • Change 0.82
  • Percent Change 1.444 %
  • Volume 219,864
  • Wed Apr 16, 2014 03:59 PM EDT NYSE data delayed 15 minutes.
  • Open 57.41
  • Previous Close 56.80
  • High 57.92
  • Low 57.01
  • Bidx3 57.49
  • Askx1 57.68
  • 52-week High03/19 62.50
  • 52-week Low05/02 40.28
  • Beta 1.515
  • Market Cap 2,772.67M
  • EPS 2.48
  • P/E 23.234
  • Forward P/E 16.66
  • PEG 1.97
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $1,165,530,000
  • Earnings $102,830,000
  • Return on Equity 15.36%

Cash Flow

  • Cash Flow --
  • Cash $155,920,000
  • Current Ratio 2.24

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $1,644,620,000
  • Liabilities $979,960,000
  • Liabilities-to-Equity Ratio 1.47

Price Ratios

  • Price to Sales 2.38
  • Price to Book 4.17
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Feb 11 $0.68 Apr 30 $0.74
Surprises Feb 11 7.35% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 16, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Charles River Laboratories is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Charles River is the global leader in providing the animal research models required in research and development for new drugs, devices and therapies and has been in this business for more than 50 years.

Related Securities
Symbol Type Latest % Chg

Officers

  • James C. Foster President; Chief Executive Off
  • Thomas F. Ackerman Chief Financial Officer and Co
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

261 BALLARDVALE STREET
WILMINGTON, MA
01887

Phone: (978)-658-6000
Fax: (978)-9885665


www.criver.com

Ideas & Discussion

Live Discussion of CRL on StockTwits